John G. Auniņš was presented the 2018 D.I.C. Wang Award for Excellence in Biochemical Engineering at the Annual Meeting in Pittsburgh on October 29, 2018, where he delivered his award lecture titled “Lessons from a Life in Biopharma.” John G. Auniņš is the Executive Vice President and Chief Technology Officer of Seres Therapeutics, Inc.
AIChE's Hailey Murphy had a chance to chat with Dr. Auniņš prior to his talk to discuss his work and congratulate him on his award. You can watch the interview in the video panel above.
Log in to post comments